Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. I. Comparison of patients with progressive and abortive lesions

Clinical and Experimental Immunology

Volumn 121, Issue 3, 2000, Pages 484-490

  Godot, V ^a   Harraga, S ^a   Beurton, I ^a   Deschaseaux, M ^a,b   Sarciron, E ^a,c   Gottstein, B ^a,d   Vuitton, D A ^a  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b Blood Transfusion Centre of Franche Comté   (France)

^c UNIVERSITÉ LYON 1   (France)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Abortive alveolar echinococcosis; Cellular immunity; IL 10; IL 5; Interferon gamma

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 5; MESSENGER RNA; PARASITE ANTIGEN; PHYTOHEMAGGLUTININ;

ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE PREDISPOSITION; ECHINOCOCCUS MULTILOCULARIS; ECHOGRAPHY; HELPER CELL; HUMAN; IMMUNE RESPONSE; INFECTION RESISTANCE; PARASITOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROLOGY;

ANIMALS; ANTIGENS, HELMINTH; CASE-CONTROL STUDIES; CYTOKINES; ECHINOCOCCOSIS; ECHINOCOCCUS; GENE EXPRESSION; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-5; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; PHYTOHEMAGGLUTININS; RNA, MESSENGER;

EID: 0033865835     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01308.x     Document Type: Article

References (28)

1. Cellular immune response in Echinococcus multilocularis infection in humans. 1) Lymphocyte reactivity to Echinococcus antigens in patients with alveolar echinococcosis
2. Echinococcosis of the liver
3. Protective immune mechanisms against the metacestode of Echinococcus multilocularis
4. IgE-dependent Humoral immune response in Echinococcus multilocularis infection: Circulating and basophil-bound specific IgE against Echinococcus antigen in patients with alveolar echinococcosis
5. Cellular immunity in experimental Echinococcus multilocularis infection. 2) Sequential and comparative phenotypic study of the periparasitic mononuclear cells in resistant and sensitive mice
6. Experimental alveolar echinococcosis. Suitability of a murine model of intrahepatic infection by Echinococcus multilocularis for immunological studies
7. Cellular immune response in Echinococcus multilocularis infection in humans. 2) Natural killer cell activity and cell subpopulations in the blood and in the periparasitic granuloma of patients with alveolar echinococcosis
8. Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis
9. IL-5 is expressed by CD4+ lymphocytes from Echinococcus multilocularis-infected patients
10. Increased basal production of interleukin-10 by peripheral blood mononuclear cells in human alveolar echinococcosis
11. In vivo treatment with recombinant IL-12 protects C57BL/6J mice against secondary alveolar echinococcosis
12. Spontaneous death of Echinococcus multilocularis: Cases diagnosed serologically (by EM2 ELISA) and clinical significance
13. Seroepidemiologic screening of Echinococcus multilocularis infection in a European area endemic for alveolar echinococcosis
14. Serological differentiation between Echinococcus granulosus and Echinococcus multilocularis infections in man
15. Determination of parasite-specific immunoglobulins using the ELISA in patients with echinococcosis treated with mebendazole
16. Immunological and morphological studies on the proliferation of in vivo cultivated Echinococcus multilocularis metacestode
17. Antibodies against Echinococcus multilocularis alkaline phosphatase as markers for the specific diagnosis and the serological monitoring of alveolar echinococcosis
18. Sero-epidemiological survey for alveolar echinococcosis (by Em2-ELISA) of blood donors in an endemic area of Switzerland
19. Mass screening and epidemiology of alveolar echinococcosis in France, western Europe, and Gansu, central China: From epidemiology towards transmission ecology
20. Specific cellular and humoral immune responses in patients with different long-term courses of alveolar echinococcosis (infection with Echinococcus multilocularis)
21. Alveolar echinococcosis
22. Production of IL-5 and IL-6 by peripheral blood mononuclear cells (PBMC) from patients with Echinococcus granulosus infection
23. In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma
24. In situ expression of interleukin-10 and interleukin-12 in active human cutaneous leishmaniasis
25. Characterization of T-cell immune responses of Echinococcus multilocularis-infected C57BL/6J mice
26. Clinical efficacy of and immunologic alterations caused by interferon gamma therapy for alveolar echinococcosis
27. Use of interferon gamma and mebendazole to stop the progression of alveolar hydatid disease: Case report
28. HLA and alveolar echinococcosis